OOIR: Observatory of International Research

Papers

(The median citation count of Current HIV/AIDS Reports is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)

Article	Citations
Understanding, Contextualizing, and Addressing PrEP Stigma to Enhance PrEP Implementation	105
The Impact of COVID-19 on HIV Care Provided via Telemedicine—Past, Present, and Future	63
COVID-19 Outcomes and Risk Factors Among People Living with HIV	52
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies	39
A Review of Interventions to Enhance HIV Medication Adherence	38
Global Systematic Review of Common Mental Health Disorders in Adults Living with HIV	34
Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine	34
The Intersection of HIV and Syphilis: Update on the Key Considerations in Testing and Management	31
COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa	30
Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations	30
NASH in HIV	26
The Past, Present, and Future of PrEP implementation Among People Who Use Drugs	25
Social Determinants of Disease: HIV and COVID-19 Experiences	23
Gastrointestinal Dysfunction and HIV Comorbidities	23
Latency Reversal 2.0: Giving the Immune System a Seat at the Table	22
Mind the Gap: HIV Prevention Among Young Black Men Who Have Sex with Men	22
Social and Behavioral Impacts of COVID-19 on People Living with HIV: Review of the First Year of Research	21
Frailty and HIV: Moving from Characterization to Intervention	20
Probing the Interface of HIV and Inflammaging	20
Mpox and HIV: a Narrative Review	18
Machine Learning and Clinical Informatics for Improving HIV Care Continuum Outcomes	18
PEPFAR’s Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa	18
Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?	17
Patient-Led Decision-Making for HIV Preexposure Prophylaxis	17
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?	16

People living with HIV and the emerging field of chronic pain—what is known about epidemiology, etiology, and management	15
Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND)	15
Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review	15
HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies	15
HIV Testing Uptake According to Opt-In, Opt-Out or Risk-Based Testing Approaches: a Systematic Review and Meta-Analysis	15
Interventions Addressing Depression and HIV-Related Outcomes in People with HIV	14
Cost-Effectiveness Analysis in Implementation Science: a Research Agenda and Call for Wider Application	14
Running with Scissors: a Systematic Review of Substance Use and the Pre-exposure Prophylaxis Care Continuum Among Sexual Minority Men	14
Telehealth Interventions for HIV in Low- and Middle-Income Countries	14
Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research	14
Non-communicable Diseases in Pregnant and Postpartum Women Living with HIV: Implications for Health Throughout the Life Course	14
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups	13
Neuroimaging the Neuropathogenesis of HIV	13
Technology-Delivered Intervention Strategies to Bolster HIV Testing	13
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups	12
HIV Pathogenesis in the Human Female Reproductive Tract	12
Socioeconomic Burdens of the COVID-19 Pandemic on LMIC Populations with Increased HIV Vulnerabilities	12
Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy	11
Aging with HIV in Latin America and the Caribbean: a Systematic Review	11
Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines	11
Risk-Based Screening Tools to Optimise HIV Testing Services: a Systematic Review	11
Peer Approaches to Improve HIV Care Cascade Outcomes: a Scoping Review Focused on Peer Behavioral Mechanisms	11
Metabolic Consequences of Antiretroviral Therapy	11
Transgender Individuals and Digital Health	11
Mapping Community-Engaged Implementation Strategies with Transgender Scientists, Stakeholders, and Trans-Led Community Organizations	10
Undernutrition and HIV Infection in Sub-Saharan Africa: Health Outcomes and Therapeutic Interventions	10
Relapse of Symptomatic Cerebrospinal Fluid HIV Escape	10
Overcoming Vaccine Hesitancy for Future COVID-19 and HIV Vaccines: Lessons from Measles and HPV Vaccines	10
Trauma-Informed HIV Care Interventions: Towards a Holistic Approach	10
Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?	10
Application of the Consolidated Framework for Implementation Research to Facilitate Violence Screening in HIV Care Settings: a Review of the Literature	9
Understanding the Evolving Role of Voluntary Medical Male Circumcision as a Public Health Strategy in Eastern and Southern Africa: Opportunities and Challenges	9
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program	9
Approaches to Promoting Linkage to and Retention in HIV Care in the United States: a Scoping Review	9
Ethical Implications of eHealth Tools for Delivering STI/HIV Laboratory Results and Partner Notifications	8
Biological Aging in People Living with HIV on Successful Antiretroviral Therapy: Do They Age Faster?	8
Impact of Antiretroviral Therapy on Cancer Treatment Outcomes among People Living with HIV in Low- and Middle-Income Countries: a Systematic Review	8
HIV Compartmentalization in the CNS and Its Impact in Treatment Outcomes and Cure Strategies	8
Applying Behavioural Insights to HIV Prevention and Management: a Scoping Review	8
Interventions to Increase HIV Testing Uptake in Global Settings	8
The Gut Microbiome, Microbial Metabolites, and Cardiovascular Disease in People Living with HIV	8
Utility of Short Message Service (SMS) for Remote Data Collection for HIV in Low- and Middle-Income Countries	8
Advances in the Experimental Models of HIV-Associated Neurological Disorders	8
HIV Care Meets Telehealth: a Review of Successes, Disparities, and Unresolved Challenges	7
Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations	7
Recruitment of US Adolescents and Young Adults (AYA) into Human Immunodeficiency Virus (HIV)–Related Behavioral Research Studies: A Scoping Review	7
Immunologic Control of HIV-1: What Have We Learned and Can We Induce It?	7
Consolidated Overview of Notifiable Adverse Events in the U.S. President’s Emergency Plan for AIDS Relief’s Voluntary Medical Male Circumcision Program Through 2020	7
Current Interventions for People Living with HIV Who Use Alcohol: Why Gender Matters	7
Diabetes in HIV: the Link to Weight Gain	7

Evidence for Implementation: Management of TB in HIV and Pregnancy	7
Microbiome Studies in Non-human Primates	7
Status-Neutral Interventions to Support Health Equity for Black Sexual Minority Men	7
Central Nervous System Effects of COVID-19 in People with HIV Infection	6
Central Nervous System Impact of Perinatally Acquired HIV in Adolescents and Adults: an Update	6
HIV and SARS-CoV-2: Tracing a Path of Vaccine Research and Development	6
How Does Voluntary Medical Male Circumcision Reduce HIV Risk?	6
Adventures in COVID-19 Policy Modeling: Education Edition	6
Immune Dysregulation in Myocardial Fibrosis, Steatosis, and Heart Failure: Current Insights from HIV and the General Population	6
Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB	6
Interventions Designed to Improve HIV Continuum of Care Outcomes for Persons with HIV in Contact with the Carceral System in the USA	6
Integrated Care Models: HIV and Substance Use	5
Viral and Host Biomarkers of HIV Remission Post Treatment Interruption	5
Trends and Clinical Characteristics of HIV and Cerebrovascular Disease in Low- and Middle-Income Countries (LMICs) Between 1990 and 2021	5
Validity of Digital Assessments in Screening for HIV-Related Cognitive Impairment: a Review	5
Novel Longitudinal Methods for Assessing Retention in Care: a Synthetic Review	5
Using Behavioral Economics to Support PrEP Adherence for HIV Prevention	5
COVID-19 Clinical Presentation Among HIV-Infected Persons in China: A Systematic Review	5
Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era	5
Implementing Implementation Research: Teaching Implementation Research to HIV Researchers	5
Measuring and Addressing Stigma Within HIV Interventions for People Who Use Drugs: a Scoping Review of Recent Research	5
Evidence for Implementation: HIV/HCV Coinfection and Pregnancy	5